Small scale, flexible Long Pharmaceuticals operates a 75,000 square foot facility with a focused team and experience in NDA/ANDA approvals, suggesting agility in custom development and scalable manufacturing for niche or specialized pharmaceutical products.

Full service partner Offering end-to-end drug product development and manufacturing, including formulation, analytical and process development, clinical trial material, packaging, stability storage, and API sourcing, positions Long as a potential single-source supplier for small to mid-sized clients.

Diversified product tech Capability across liquids, suspensions, semi-solids, and tablets indicates versatility to support multiple dosage forms for customer pipelines, enabling expansion into new formulations or reformulations.

Growth opportunists With a lean revenue footprint yet proven regulatory track record, there is opportunity to target biotech startups, specialty pharma, and contract development organizations seeking reliable manufacturing partners for early-phase to commercial products.

Digital footprint Tech stack includes OpenResty and common web servers, suggesting potential for enhanced digital marketing support, e-commerce enablement for CDMO services, and improved client onboarding and materials management.